Brian M. Stolz is EVP & Administration & CHCO at Valeant Pharmaceuticals International, Inc. (VRX). They have made 7 open-market trades across 2 companies since 2011, most recently 2020-08-16.
CIK 0001524803
6 open-market purchases totalling $1.1M since 2011, against 1 sale. Across 6 scored buys the stock is up 0.4% at ninety days, and 0.2 points ahead of the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 100% | 100% |
| Avg Move | -12.8% | +0.4% | +0.4% |
| Alpha | -7.0% | +0.2% | +0.2% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ATVI | SELL | 2019-08-13 | 2019-08-15 | $47.80 | $6.4M | +11.2% | +21.4% | +13.9% |
| VRX | BUY | 2013-08-12 | 2013-08-12 | $100.71 | $453K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2012-11-07 | 2012-11-08 | $52.76 | $108K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2012-05-10 | 2012-05-14 | $53.10 | $266K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2011-11-17 | 2011-11-18 | $42.05 | $101K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2011-08-26 | 2011-08-30 | $41.00 | $110K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2011-08-09 | 2011-08-11 | $39.18 | $100K | -12.8% | +0.4% | +0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.